Cure of advanced gastric cancer by combined chemotherapy with cisplatinum, mitomycin C, and 5‐fluorouracil
- 1 May 1988
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 38 (1) , 26-32
- https://doi.org/10.1002/jso.2930380109
Abstract
A 55-year-old female, in which an unresectable Borrmann II-type gastric cancer (moderately differentiated adenocarcinoma) extending from vicinity of the cardia to the lower portion of the corpus, with direct invasion into the pancreas and extensive lymph node metastases, confirmed by laparotomy, was treated postoperatively by 3 courses of chemotherapy with cisplatinum in combination with mitomycin C and 5-fluorouracil. A complete response was confirmed by roentgenography and endoscopy, and, at 4 months after the first operation, a total gastrectomy with radical lymphadenectomy was performed successfully. Cancer cells were not detectable histologically in the stomach specimen and in all the lymph nodes removed. One year and 5 months after the second operation she is well, showing no sign of recurrence.This publication has 4 references indexed in Scilit:
- Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancerCancer Chemotherapy and Pharmacology, 1985
- Cisplatin.An active drug in the treatment of disseminated gastric cancerCancer, 1984
- A phase II study of cisplatin in advanced gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1983